Tag: abbvie

abbvie

Latest News

Samsung Bioepis' Humira biosimilar Hadlima, left, and Celltrion Healthcare's Yuflyma [SAMSUNG BIOEPIS/CELLTRION HEALTHCARE]

Pharma firms scramble for slice of lucrative Humira market

A frenzied battle has begun between rival suppliers after the company behind Humira, the world’s top-selling drug for over a decade, lost its exclusive patent protection for the autoimmune treatment.

2023.7.3

Celltrion to sell Yuflyma in U.S. from July next year

Celltrion said Wednesday it has reached an agreement with AbbVie that allows it to sell its biosimilar product of Humira in the U.S. market starting July next year.

2022.4.27

Celltrion's CT-P17 biosimilar approved for use in Korea

Celltrion's CT-P17 biosimilar was approved for sale in Korea, the company said Friday.

2021.10.15

Tag: abbvie

abbvie

Latest News

Pharma firms scramble for slice of lucrative Humira market

Celltrion to sell Yuflyma in U.S. from July next year

Most popular

Veteran actors Yoo Hae-jin, Ryu Seung-ryong win Baeksang Grand Prizes — as it happened

BTS comeback: Bright lights and drone shows light up the sky as 'Arirang' finally arrives — as it happened

Yoon Suk Yeol sentenced to life in prison for insurrection — as it happened

North Korea releases new photos of Kim Jong-un to quash death rumors

Rooney, Maicon, Park Joo-ho score as Shield United wins Icons Match in Seoul — as it happened

Celltrion's CT-P17 biosimilar approved for use in Korea